Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.84 USD
−112.96 M USD
1.16 M USD
4.63 M
About Q32 Bio Inc.
Sector
Industry
CEO
Jodie P. Morrison
Website
Headquarters
Waltham
Founded
2017
FIGI
BBG00CTTJWQ9
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of QTTB is 3.31 USD — it has decreased by −10.03% in the past 24 hours. Watch Q32 Bio Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Q32 Bio Inc. stocks are traded under the ticker QTTB.
QTTB stock has fallen by −13.40% compared to the previous week, the month change is a −88.04% fall, over the last year Q32 Bio Inc. has showed a −66.57% decrease.
We've gathered analysts' opinions on Q32 Bio Inc. future price: according to them, QTTB price has a max estimate of 22.00 USD and a min estimate of 9.00 USD. Watch QTTB chart and read a more detailed Q32 Bio Inc. stock forecast: see what analysts think of Q32 Bio Inc. and suggest that you do with its stocks.
QTTB reached its all-time high on Feb 27, 2019 with the price of 572.40 USD, and its all-time low was 3.02 USD and was reached on Dec 18, 2024. View more price dynamics on QTTB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
QTTB stock is 6.03% volatile and has beta coefficient of 1.17. Track Q32 Bio Inc. stock price on the chart and check out the list of the most volatile stocks — is Q32 Bio Inc. there?
Today Q32 Bio Inc. has the market capitalization of 39.34 M, it has decreased by −42.35% over the last week.
Yes, you can track Q32 Bio Inc. financials in yearly and quarterly reports right on TradingView.
Q32 Bio Inc. is going to release the next earnings report on Mar 7, 2025. Keep track of upcoming events with our Earnings Calendar.
QTTB earnings for the last quarter are −1.46 USD per share, whereas the estimation was −1.38 USD resulting in a −5.87% surprise. The estimated earnings for the next quarter are −1.53 USD per share. See more details about Q32 Bio Inc. earnings.
Q32 Bio Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
QTTB net income for the last quarter is −17.59 M USD, while the quarter before that showed −16.98 M USD of net income which accounts for −3.63% change. Track more Q32 Bio Inc. financial stats to get the full picture.
No, QTTB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 7.00 employees. See our rating of the largest employees — is Q32 Bio Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Q32 Bio Inc. EBITDA is −60.62 M USD, and current EBITDA margin is −7.92 K%. See more stats in Q32 Bio Inc. financial statements.
Like other stocks, QTTB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Q32 Bio Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Q32 Bio Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Q32 Bio Inc. stock shows the sell signal. See more of Q32 Bio Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.